Cargando…
B-Cell-Mediated Strategies to Fight Chronic Allograft Rejection
Solid organs have been transplanted for decades. Since the improvement in graft selection and in medical and surgical procedures, the likelihood of graft function after 1 year is now close to 90%. Nonetheless even well-matched recipients continue to need medications for the rest of their lives hence...
Autor principal: | Dalloul, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865384/ https://www.ncbi.nlm.nih.gov/pubmed/24381571 http://dx.doi.org/10.3389/fimmu.2013.00444 |
Ejemplares similares
-
Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells
por: Matsuda, Yoshiko, et al.
Publicado: (2021) -
Immune Checkpoints Expression in Chronic Lung Allograft Rejection
por: Righi, Ilaria, et al.
Publicado: (2021) -
Allorecognition by T Lymphocytes and Allograft Rejection
por: Marino, Jose, et al.
Publicado: (2016) -
Role of Memory T Cells in Allograft Rejection and Tolerance
por: Benichou, Gilles, et al.
Publicado: (2017) -
The Immunological Basis of Liver Allograft Rejection
por: Ronca, Vincenzo, et al.
Publicado: (2020)